临床儿科杂志 ›› 2021, Vol. 39 ›› Issue (5): 391-.doi: 10.3969/j.issn.1000-3606.2021.05.016

• 文献综述 • 上一篇    下一篇

肠道病毒71 型疫苗研究进展

毕方川综述 许红梅审校   

  1. 重庆医科大学附属儿童医院感染科 儿童发育疾病研究教育部重点实验室 国家儿童健康与疾病临床 医学研究中心 儿童发育重大疾病国家国际科技合作基地 儿科学重庆市重点实验室(重庆 400014)
  • 发布日期:2021-05-07
  • 基金资助:
    国家科技重大专项“艾滋病和病毒性肝炎等重大传染病防治”资助项目(No. 2018 ZX 10713 -002)

Research progress on enterovirus 71 vaccines

Reviewer: BI Fangchuan, Reviser: XU Hongmei   

  1. (Department of Infectious Diseases, Children’s Hospital of Chongqing Medical University, Ministry of Education Key Laboratory of Child Development and Disorders, National Clinical Research Center for Child Health and Disorder, China International Science and Technology Cooperation Base of Child Development and Critical Disorders, Chongqing Key Laboratory of Pediatrics, Chongqing 400014, China
  • Published:2021-05-07

摘要: 手足口病(HFMD)是一种婴幼儿常见的传染性疾病。肠道病毒71型(EV-A 71)是HFMD的主要病原之一, 可导致严重并发症甚至造成死亡。因此,预防EV-A71感染尤为必要。开发EV-A71疫苗是预防、控制EV-A71感染最有效 的方法。正在研发的EV-A 71疫苗主要包括:灭活全病毒疫苗、减毒活疫苗、病毒样颗粒疫苗、重组VP 1蛋白疫苗和合成 多肽疫苗。现就EV-A 71候选疫苗的开发和进展作一综述。

关键词: 手足口病; 肠道病毒71型; 疫苗

Abstract: Hand, foot and mouth disease (HFMD) is a common infectious disease in infants and young children. Enterovirus 71 (EV-A 71 ) is one of the main pathogens of HFMD, which could cause serious complications and even death. Therefore, it is an urgent need to protect against EV-A 71 infection. Development of EV-A 71 vaccine would be the most effective approach to prevent and control EV-A 71 infection. The EV-A 71 vaccines under development mainly include inactivated vaccines, attenuated live vaccines, virus-like particle vaccines, recombinant epitope vaccines, and synthetic peptide vaccines. This article summarizes the progress and development of the EV-A 71 vaccine.

Key words: hand, foot and mouth disease; enterovirus A 71 ; vaccine